VP, GM-Infusion Capital
Avg Cost/Share
$152.35
Shares
2,897
Total Value
$441,364.32
Owned After
11,297
SEC Form 4
VP, GM-Infusion Capital
Avg Cost/Share
$156.25
Shares
2,241
Total Value
$350,158.49
Owned After
11,297
SEC Form 4
VP, GM-Infusion Capital
Avg Cost/Share
$163.22
Shares
2,502
Total Value
$408,370.19
Owned After
11,297
SEC Form 4
VP, GM-Infusion Capital
Avg Cost/Share
$98.27
Shares
791
Total Value
$77,732.76
Owned After
11,297
SEC Form 4
VP, GM-Infusion Capital
Avg Cost/Share
$88.03
Shares
1,729
Total Value
$152,196.26
Owned After
11,297
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Woolson Daniel | ICUI | VP, GM-Infusion Capital | Nov 25, 2025 | Sell | $152.35 | 2,897 | $441,364.32 | 11,297 | |
| Woolson Daniel | ICUI | VP, GM-Infusion Capital | Dec 6, 2024 | Sell | $156.25 | 2,241 | $350,158.49 | 11,297 | |
| Woolson Daniel | ICUI | VP, GM-Infusion Capital | Aug 30, 2024 | Sell | $163.22 | 2,502 | $408,370.19 | 11,297 | |
| Woolson Daniel | ICUI | VP, GM-Infusion Capital | Mar 15, 2024 | Sell | $98.27 | 791 | $77,732.76 | 11,297 | |
| Woolson Daniel | ICUI | VP, GM-Infusion Capital | Dec 1, 2023 | Sell | $88.03 | 1,729 | $152,196.26 | 11,297 |